(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Successful cancer chemotherapy relies heavily on the application of various deoxynucleoside analogs. Since the very beginning of modern cancer chemotherapy, a number of antimetabolites have been introduced into the clinic and subsequently applied widely for the treatment of many malignancies, both solid tumors and hematological disorders. In the latter diseases, cytarabine has been the mainstay of treatment of acute myeloid leukemia. Although many novel compounds were synthesized in the 1980s and 1990s, no real improvement was made. However, novel technology is now capable of elucidating the molecular basis of several inborn errors as well as some specific malignancies. This has enabled the synthesis of several deoxynucleoside analogs that could be applied for specific malignancies, such as pentostatin and subsequently chlorodeoxyadenosine (cladribine) for the treatment of hairy cell leukemia. Already in the early stage of deoxynucleoside analog development, it was recognized that several of these compounds were very effective in the treatment of various viral infections, such as for the treatment of herpes infections. This formed the basis initially for the design of azidothymidine and subsequently many other analogs, which are currently successfully used for the treatment of HIV infections. As a spin-off of these research lines, some compounds not eligible for development as antiviral agents appeared to be very potent anticancer agents. The classical example is gemcitabine, now one of the most widely applied deoxynucleoside analogs, used for the (combination) treatment of non-small cell lung cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Contents:
Nucleoside Transport into Cells: The Role of Nucleoside Transporters SLC28 and SLC29 in Cancer Chemotherapy
Marcal Pastor-Anglada and F. Javier Casado
The Role of Deoxycytidine Kinase in DNA Synthesis and Nucleoside Analog Activation
Maria Staub and Staffan Eriksson
Deoxynucleoside Kinases and Their Potential Role in Deoxynucleoside Cytotoxicity
Birgitte Munch-Petersen and Jure Piskur
Nucleotidases and Nucleoside Analog Cytotoxicity
Sally Anne Hunsucker, Beverly S. Mitchell, and Jozef Spychala
Pumping Out Drugs: The Potential Impact of ABC Transporters on Resistance to Base, Nucleoside, and Nucleotide Analogs
Piet Borst and Peter Wielinga
Cytosine Arabinoside: Metabolism, Mechanisms, of Resistance, and Clinical Pharmacology
Isabelle Hubeek, G. J. L. Kaspers, G Ossenkoppele, and G. J. Peters
Clofarabine: Mechanisms of Action, Pharmacology, and Clinical Investigation
Varsha Gandhi and William Plunkett
L-Nucleosides as Chemotherapeutic Agents
Giuseppe Gumina, Youhoon Chong, and Chung K. Chu
Troxacitabine: A Deoxycytidine Nucleoside Analogue With Potent Antitumor Activity
Henriette Gourdeau and Jacques Jolivet
9-b-D-arabinofuranosylguanine
Sophie Curbo
Gemcitabine: Mechanism of Action and Resistance
A. M. Bergman and G.J. Peters
Clinical Activity of Gemcitabine as a Single Agent and in Combination
J. R. Kroep, GJ Peters, and RA Nagourney
Nucleoside Radiosensitizers
Donna S. Shewach and Theodore S. Lawrence
NONMEM Population Models of Cytosine Arabinoside and Flubaradine Phosphate in Pediatric Patients with Leukemia
Vassilios I. Avramis
The cycloSal-Nucleotide Delivery System: Development of Chemical Trojan Horses as Antiviral Agents
Chris Meier, Jan Balzarini, and Astrid Meerbach
Purine and Pyrimidine Based Analogs and Suicide GeneTherapy
Zoran Gojkovic
3'-deoxy-3'- Fluorothymidine as a Tracer if Proliferation in Positron Emission Tomography
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: November, 2010
Pages: 492
Weight: 717g
Availability: Available
Subcategories: Oncology
Publisher recommends
Godefridus J. Peters
From the same series
Nicola Curtin
Jorge J. Castillo
Moulay A. Alaoui-Jamali
Gail Lewis Phillips
Frank E. Koehn
Beverly A. Teicher
Gary J. Kelloff
Ryan J. Sullivan
Gary K Schwartz
Val R Adams
Antonio Tito Fojo
William D. Figg
Steven Kanner
Giovanni Melillo
Masaki Terabe
Yves Pommier
Derek LeRoith
Beverly A. Teicher
Ann L. Jackman
Jorge J. Castillo
Manuel Hidalgo
Vinata B. Lokeshwar
Beverly A. Teicher
Moulay A. Alaoui-Jamali
Saïd M. Sebti
Frank E. Koehn
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
Beverly A. Teicher
Alan M. Gewirtz
Michael A Morse
Janusz W. Rak
J. Silvio Gutkind
Maryann Foote
Zahid H. Siddik
L. Harivardhan Reddy
Gavin J. Gordon
Masaki Terabe
Yves Pommier
Derek LeRoith
Neil J. Clendeninn
Howard L. Kaufman
John D. Haley
Manuel Hidalgo
Beverly A. Teicher
Ulrike Stein
Pat Price
Kelly K. Hunt
Mary L. Disis
David A. Gewirtz
Beverly A. Teicher
Sayed S. Daoud
Nicholas P. Farrell
Vinata B. Lokeshwar
Beverly A. Teicher
Giampietro Gasparini
Doriano Fabbro
Nicholas B. La Thangue
David E. Fisher
Beverly A. Teicher
John A. Hickman
Julian Adams
Sonia Jakowlew
Antonio Giordano
Youcef M. Rustum
Michel Page
Gurmit Singh
Gary J. Kelloff
Moulay A. Alaoui-Jamali
Wafik S. El-Deiry
Keiko Hiyama
Amy M. Fulton
Federico Innocenti
Hak Choy
Sonia Jakowlew
Dennis M. Brown
Michael T. Lotze
Randall E. Harris
Eric Verdin
Benjamin Bonavida
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
L. Harivardhan Reddy
V. Craig Jordan
Zahid H. Siddik
Erwin G. van Meir
Amy M. Fulton
Beverly A. Teicher
Keiko Hiyama
Gavin J. Gordon
David S. Ettinger
Federico Innocenti
John D. Haley
Benjamin Bonavida
Antonio Tito Fojo
Sonia Jakowlew
Sonia Jakowlew
Howard L. Kaufman
David A. Gewirtz
Beverly A. Teicher
Sayed S. Daoud
Pat Price
Michael T. Lotze
Ulrike Stein
Kelly K. Hunt
Godefridus J. Peters
Beverly A. Teicher
Eric Verdin